Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus, J Virol, vol.72, pp.3539-3546, 1998. ,
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome, Nature Medicine, vol.37, issue.7, pp.791-796, 2005. ,
DOI : 10.1002/jmv.10297
Complete replication of hepatitis C virus in cell culture, Science, vol.309, pp.623-626, 2005. ,
Robust hepatitis C virus infection in vitro, Proceedings of the National Academy of Sciences, vol.102, issue.26, pp.9294-9299, 2005. ,
DOI : 10.1073/pnas.0503596102
Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate, Journal of Biological Chemistry, vol.278, issue.42 ,
DOI : 10.1074/jbc.M302267200
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells., Proc. Natl. Acad. Sci, 1996. ,
DOI : 10.1073/pnas.93.5.1759
Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes, J Virol, vol.79, pp.5774-5785, 2005. ,
Uptake and presentation of hepatitis C virus-like particles by human dendritic cells, Blood, vol.105, pp.3605-3614, 2005. ,
Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry, J. Virol, vol.76, pp.9335-9344, 2002. ,
Structural Features of Envelope Proteins on Hepatitis C Virus-like Particles as Determined by Anti-envelope Monoclonal Antibodies and CD81 Binding, Virology, vol.298, issue.1, pp.124-132, 2002. ,
DOI : 10.1006/viro.2002.1463
Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate Interaction, Journal of Virology, vol.80, issue.21, pp.10579-10590, 2006. ,
DOI : 10.1128/JVI.00941-06
In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes, Proceedings of the National Academy of Sciences, vol.100, issue.24, pp.14199-14204, 2003. ,
DOI : 10.1073/pnas.2335981100
An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both 14 ,
Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1, Proceedings of the National Academy of Sciences, vol.102, issue.12, pp.4560-4565, 2005. ,
DOI : 10.1073/pnas.0501275102
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C, Proceedings of the National Academy of Sciences, vol.104, issue.14, pp.6025-6030, 2007. ,
DOI : 10.1073/pnas.0607026104
URL : https://hal.archives-ouvertes.fr/inserm-00395910
The neutralizing activity of anti-HCV antibodies is modulated by specific glycans on the E2 envelope protein, J Virol, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00183359
Characterization of Vesicular Stomatitis Virus Recombinants That Express and Incorporate High Levels of Hepatitis C Virus Glycoproteins, Journal of Virology, vol.76, issue.14, pp.6865-6872, 2002. ,
DOI : 10.1128/JVI.76.14.6865-6872.2002
Coexpression of Hepatitis C Virus E1 and E2 Chimeric Envelope Glycoproteins Displays Separable Ligand Sensitivity and Increases Pseudotype Infectious Titer, Journal of Virology, vol.78, issue.23, pp.12838-12847, 2004. ,
DOI : 10.1128/JVI.78.23.12838-12847.2004
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro, Proceedings of the National Academy of Sciences, vol.103, issue.10, pp.3805-3809, 2006. ,
DOI : 10.1073/pnas.0511218103
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras, Proceedings of the National Academy of Sciences, vol.103, issue.19, pp.7408-7413, 2006. ,
DOI : 10.1073/pnas.0504877103
Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells, Proceedings of the National Academy of Sciences, vol.103, issue.7, pp.2310-2315, 2006. ,
DOI : 10.1073/pnas.0510727103
A critical role for the chimpanzee model in the study of hepatitis C, Hepatology, vol.173, issue.6, pp.1469-1475, 2004. ,
DOI : 10.1002/hep.20268
Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization., Proceedings of the National Academy of Sciences, vol.91, issue.16, pp.7792-7796, 1994. ,
DOI : 10.1073/pnas.91.16.7792
Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein, Proceedings of the National Academy of Sciences, vol.93, issue.26 ,
DOI : 10.1073/pnas.93.26.15394
Vaccination of chimpanzees against infection by the hepatitis C virus., Proceedings of the National Academy of Sciences, vol.91, issue.4 ,
DOI : 10.1073/pnas.91.4.1294
Lack of protective immunity against reinfection with hepatitis C virus, Science, vol.258, pp.135-140, 1992. ,
Immunity in Hepatitis C Infection, Journal of Infectious Diseases, vol.165, issue.3, pp.438-443, 1992. ,
DOI : 10.1093/infdis/165.3.438
Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection, Hepatology, vol.33, issue.6, pp.1479-1487, 2001. ,
DOI : 10.1053/jhep.2001.24371
Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge, Journal of Virology, vol.76, issue.13, pp.6586-6595, 2002. ,
DOI : 10.1128/JVI.76.13.6586-6595.2002
Cross-Genotype Immunity to Hepatitis C Virus, Journal of Virology, vol.78, issue.3, pp.1575-1581, 2004. ,
DOI : 10.1128/JVI.78.3.1575-1581.2004
Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses, Journal of Virology, vol.80, issue.11, pp.5308-5320, 2006. ,
DOI : 10.1128/JVI.02460-05
Scavenger receptor BI is a key host factor for Hepatitis C virus infection required for an entry step closely linked to CD81 Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry, Nature, vol.446, pp.801-805, 2007. ,
Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis, Journal of Virology, vol.80, issue.14, pp.6964-6972, 2006. ,
DOI : 10.1128/JVI.00024-06
URL : https://hal.archives-ouvertes.fr/hal-00105504
Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles, Journal of Virology, vol.80, issue.23, pp.11571-11578, 2006. ,
DOI : 10.1128/JVI.01717-06
Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis, Journal of General Virology, vol.87, issue.9, pp.2583-2593, 2006. ,
DOI : 10.1099/vir.0.81710-0
Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry, Journal of Virology, vol.80, issue.4, pp.1734-1741, 2006. ,
DOI : 10.1128/JVI.80.4.1734-1741.2006
Hepatitis C virus entry: Molecular biology and clinical implications, Hepatology, vol.7, issue.3, pp.527-535, 2006. ,
DOI : 10.1002/hep.21321
Occupancy and mechanism in antibody-mediated neutralization of animal viruses, Journal of General Virology, vol.83, issue.9, pp.2091-2108, 2002. ,
DOI : 10.1099/0022-1317-83-9-2091
Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein, Journal of Virology, vol.79, issue.17, pp.11095-11104, 2005. ,
DOI : 10.1128/JVI.79.17.11095-11104.2005
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection, Journal of Virology, vol.78, issue.3, pp.1448-1455, 2004. ,
DOI : 10.1128/JVI.78.3.1448-1455.2004
Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding, J Virol, vol.80, pp.8695-8704, 2006. ,
Characterization of Human Monoclonal Antibodies Specific to the Hepatitis C Virus Glycoprotein E2 within VitroBinding Neutralization Properties, Virology, vol.249, issue.1, pp.32-41, 1998. ,
DOI : 10.1006/viro.1998.9202
Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity, Hepatology, vol.78, issue.7959, pp.1055-1062, 2005. ,
DOI : 10.1002/hep.20906
Characterization of Functional Hepatitis C Virus Envelope Glycoproteins, Journal of Virology, vol.78, issue.6 ,
DOI : 10.1128/JVI.78.6.2994-3002.2004
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33, Hepatology, vol.399, issue.3, pp.592-601, 2006. ,
DOI : 10.1002/hep.21088
Characterization of Fusion Determinants Points to the Involvement of Three Discrete Regions of Both E1 and E2 Glycoproteins in the Membrane Fusion Process of Hepatitis C Virus, Journal of Virology, vol.81, issue.16 ,
DOI : 10.1128/JVI.02642-06
Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection, The Lancet, vol.346, issue.8981, pp.1006-1007, 1995. ,
DOI : 10.1016/S0140-6736(95)91691-1
Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection, The Journal of Experimental Medicine, vol.43, issue.10, pp.1395-1406, 2001. ,
DOI : 10.1126/science.284.5415.825
Incidence of Hepatitis C in Patients Receiving Different Preparations of Hepatitis B Immunoglobulins after Liver Transplantation, Annals of Internal Medicine, vol.128, issue.10, pp.810-816, 1998. ,
DOI : 10.7326/0003-4819-128-10-199805150-00003
Five-Year Follow-up of Patients with Primary Antibody Deficiencies Following an Outbreak of Acute Hepatitis C, Clinical Immunology, vol.99, issue.3, pp.320-324, 2001. ,
DOI : 10.1006/clim.2001.5036
Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up, Clinical and Experimental Immunology, vol.110, issue.1, pp.4-8, 1997. ,
DOI : 10.1111/j.1365-2249.1997.508-ce1412.x
Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma, Proceedings of the National Academy of Sciences, vol.101, issue.20, pp.7705-7710, 2004. ,
DOI : 10.1073/pnas.0402458101
Neutralizing antibody response during acute and chronic hepatitis C virus infection, Proceedings of the National Academy of Sciences, vol.101, issue.27, pp.10149-10154, 2004. ,
DOI : 10.1073/pnas.0403519101
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC454180
Humoral Immune Response in Acute Hepatitis C Virus Infection, Clinical Infectious Diseases, vol.41, issue.5, pp.667-675, 2005. ,
DOI : 10.1086/432478
Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection, Journal of Virology, vol.79, issue.10, pp.6023-6034, 2005. ,
DOI : 10.1128/JVI.79.10.6023-6034.2005
High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI, Journal of Biological Chemistry, vol.281, issue.27, pp.18285-18295, 2006. ,
DOI : 10.1074/jbc.M602706200
URL : https://hal.archives-ouvertes.fr/hal-00313930
Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodies, Proceedings of the National Academy of Sciences, vol.100, issue.22, pp.12883-12888, 2003. ,
DOI : 10.1073/pnas.2135542100
Viral persistence in vivo through selection of neutralizing antibody-escape variants, Proceedings of the National Academy of Sciences, vol.97, issue.6, pp.2749-2754, 2000. ,
DOI : 10.1073/pnas.040558797
Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C, Nat. Med, vol.6, pp.578-582, 2000. ,
Adaptive immune responses in acute and chronic hepatitis C virus infection, Nature, vol.38, issue.7053, pp.946-952, 2005. ,
DOI : 10.1128/JVI.78.3.1575-1581.2004
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites, Nature, vol.85, issue.6916, pp.678-682, 2002. ,
DOI : 10.1128/JVI.74.4.1961-1972.2000
The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies, Science, vol.288, pp.339-344, 2000. ,
Role of Neutralizing Antibodies in Protective Immunity Against HIV, Human Vaccines, vol.1, issue.2, pp.45-60, 2005. ,
DOI : 10.4161/hv.1.2.1764
Induction of Hepatitis C Virus E1 Envelope Protein-Specific Immune Response Can Be Enhanced by Mutation of N-Glycosylation Sites, Journal of Virology, vol.75, issue.24, pp.12088-12097, 2001. ,
DOI : 10.1128/JVI.75.24.12088-12097.2001
Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor CD81, J. Virol, vol.73, pp.6235-6244, 1999. ,